pharmaphorum Podcast
Episodes
Galapagos UK’s Michael Smyth on COVID and RNA-based tech: the pharmaphorum podcast
30 Apr 2021
Contributed by Lukas
Episode 35 of the pharmaphorum podcast heard from Michael Smyth about Galapagos UK and joining the company as medical director just as COVID-19 hit.
Big data and cell therapy development: the pharmaphorum podcast
20 Apr 2021
Contributed by Lukas
In the latest episode of the podcast pharmaphorum’s website editor Catherine Longworth speaks with Dr. Darrin Disley, CEO of UK biotech Mogrify
GSK on COVID and vaccine development: the pharmaphorum podcast
31 Mar 2021
Contributed by Lukas
In the latest episode of the podcast Dominic Tyer speaks with GlaxoSmithKline’s Philip Cruz about the discovery and commercialisation of new vaccine...
The meaning of digital innovation: the pharmaphorum podcast
23 Mar 2021
Contributed by Lukas
This instalment of the podcast considers the meaning of digital innovation, both in pharma and outside the industry, and features digital transformati...
New ways to treat COVID: the pharmaphorum podcast
12 Mar 2021
Contributed by Lukas
In episode 31 of the pharmaphorum podcast, Deep Dive editor George Underwood speaks to RedHill biopharma’s chief business officer Guy Goldberg about...
The Alderley Park Discovery Podcast: The journey to accessing science funding and investment
08 Mar 2021
Contributed by Lukas
Episode 3 of the Alderley Park Discovery Podcast covers how to successfully access life science funding and investment, highlighting a range of ways ...
Roche on COVID healthcare and testing: the pharmaphorum podcast
26 Feb 2021
Contributed by Lukas
For episode 30 I spoke with Dr Ashton Harper, who’s head of medical affairs in the UK and Ireland at Roche Diagnostics, about the pressure COVID-19 ...
Richard Francis discusses his new role as Purespring’s CEO: pharmaphorum podcast
12 Feb 2021
Contributed by Lukas
In this episode of the pharmaphorum podcast, our news editor Richard Staines talks to Richard Francis, who took over as CEO of gene therapy company Pu...
AstraZeneca’s Rebekah Martin on diversity and inclusion: the pharmaphorum podcast
29 Jan 2021
Contributed by Lukas
The theme for episode 28 of the pharmaphorum podcast is diversity and inclusion in pharma, ably addressed by AstraZeneca’s Rebekah Martin. Serving a...
The Alderley Park Discovery Podcast: Life science skills, staffing and support
05 Jan 2021
Contributed by Lukas
Episode two of the Alderley Park Discovery Podcast covers access to skills in the life sciences sector, with a focus on support for aspiring scientist...
J&J and medical device innovation: the pharmaphorum podcast
21 Dec 2020
Contributed by Lukas
In episode 27 of the pharmaphorum podcast I’m joined by Erin McEachren, who’s EU Regional Vice President at J&J Surgical Vision. She talks about h...
Biotech trends in COVID era: the pharmaphorum podcast
30 Nov 2020
Contributed by Lukas
In episode 26 the pharmaphorum podcast hears from David Solomon, a 30-year life sciences industry veteran who recently took up the position of CEO at ...
GSK and eosinophil research: the pharmaphorum podcast
30 Oct 2020
Contributed by Lukas
GlaxoSmithKline’s Nucala (mepolizumab) last month became the first and only biologic treatment approved in the US for Hypereosinophilic Syndrome (HE...
Gitte Aabo on telemedicine and her time at LEO Pharma: the pharmaphorum podcast
28 Sep 2020
Contributed by Lukas
In this episode of the podcast Gitte discusses telemedicine, GN Hearing’s work in this area – and the impact of COVID-19, plus her time at LEO Pha...
The Alderley Park Discovery Podcast: COVID testing and the Lighthouse Lab
15 Sep 2020
Contributed by Lukas
The Alderley Park Discovery Podcast, produced in partnership with pharmaphorum, presents perspectives on UK and global bioscience innovation trends, w...
Alnylam, gene-silencing and biotech in 2020: the pharmaphorum podcast
27 Aug 2020
Contributed by Lukas
Anlnylam’s Brendan Martin joined the pharmaphorum podcast for episode 23 to talk about his company’s work in gene-silencing and how it could offer...
Novartis, company culture and COVID-19: the pharmaphorum podcast
30 Jul 2020
Contributed by Lukas
Novartis’ Steven Baert joined the pharmaphorum podcast for episode 22 to discuss how COVID-19 will change the face
Amgen and science education: the pharmaphorum podcast
30 Jun 2020
Contributed by Lukas
Harvard University launched LabXchange in January and the free science education platform has acquired new resonance during the
UK pharma leadership and COVID-19: the pharmaphorum podcast
29 May 2020
Contributed by Lukas
The COVID-19 pandemic has forced significant changes on the pharmaceutical industry as companies scramble to protect employees, ensure
Eisai and Alexa skills in epilepsy: the pharmaphorum podcast
02 Apr 2020
Contributed by Lukas
Voice technology like Amazon’s Alexa is taking some big steps forward in healthcare and in the pharmaceutical world
Digital health and interoperability: the pharmaphorum podcast
09 Mar 2020
Contributed by Lukas
One of the biggest barriers to applying precision medicine to clinical trials and patient engagement is getting different
Roche, big data and patient outcomes: the pharmaphorum podcast
08 Jan 2020
Contributed by Lukas
In the first pharmaphorum podcast of 2020 Roche’s Conor Megaw talks about his company’s approach to big data
Pfizer and the UK cancer landscape: the pharmaphorum podcast
11 Dec 2019
Contributed by Lukas
Pfizer’s Dr Olivia Ashman joined me for episode 16 of the pharmaphorum podcast, which focuses on the UK
Life sciences leadership: the pharmaphorum podcast
14 Nov 2019
Contributed by Lukas
Episode 15 of the pharmaphorum podcast marked a return visit for leading life sciences industry authority Professor Brian
AstraZeneca and lung cancer: the pharmaphorum podcast
07 Aug 2019
Contributed by Lukas
This episode of the pharmaphorum podcast focuses on lung cancer, with AstraZeneca’s VP, Global Franchise Head, Tagrisso TDR
Lung cancer’s patient information gap: the pharmaphorum podcast
06 Aug 2019
Contributed by Lukas
For episode 13 of the pharmaphorum podcast I went to AstraZeneca’s London base to meet Paul Naish, who’s
The state of UK drug discovery: the pharmaphorum podcast
19 Jul 2019
Contributed by Lukas
The UK environment for drug discovery, the impact of artificial intelligence (AI) on medicines research and the role of complex cell models were all o...
Addressing global health challenges: the pharmaphorum podcast
19 Jun 2019
Contributed by Lukas
For episode 11 of the pharmaphorum podcast our CEO and founder Dr Paul Tunnah took the helm to record a special roundtable episode in Philadelphia wit...
Gene therapy and market access: the pharmaphorum podcast
31 May 2019
Contributed by Lukas
For episode 10 of the pharmaphorum podcast I spoke to Nicola Redfern, who’s general manager at bluebird bio in the UK. The Cambridge, Massachusetts-...
AMR research and Matoke Pharma: the pharmaphorum podcast
13 May 2019
Contributed by Lukas
Re-engineered honey has proved to be a novel and successful development for Matoke Pharma, as well as a crucial step on the UK biotech company’s pla...
GSK and digital disruption: the pharmaphorum podcast
05 Apr 2019
Contributed by Lukas
Digital innovation and disruption in healthcare are the subject of this episode of the pharmaphorum podcast, for which I visited GlaxoSmithKline at th...
Ipsen on neurotoxin research: the pharmaphorum podcast
28 Mar 2019
Contributed by Lukas
For episode 7 of the pharmaphorum podcast I spoke to Ipsen’s Philippe Picaut about neurotoxin research, with a particular focus on Botulinum neuroto...
Successful medical marketing teams: the pharmaphorum podcast
22 Feb 2019
Contributed by Lukas
The pharmaphorum podcast’s first episode of 2019 features Professor Brian D Smith on what makes a modern, and successful, medical marketing team.
Biotech strategy and nanomedicine: the pharmaphorum podcast
21 Dec 2018
Contributed by Lukas
For episode 5 of the pharmaphorum podcast Dominic Tyer met Blueberry Therapeutics’ CEO Dr John Ridden at The Wellcome Collection in London to talk a...
Commercialising orphan drugs: the pharmaphorum podcast
20 Nov 2018
Contributed by Lukas
In episode 4 of the podcast pharmaphorum talked to Dr Joe Wiley, CEO of UK-based biopharmaceutical company Amryt Pharma, about its strategy and work i...
The future biosimilar landscape: the pharmaphorum podcast
16 Oct 2018
Contributed by Lukas
For episode 3 of the pharmaphorum podcast Dominic Tyer went to the UK headquarters of Sandoz to meet the head of the company’s UK specialty business...
Nimble consumer healthcare innovation: the pharmaphorum podcast
14 Sep 2018
Contributed by Lukas
In episode 2 of the podcast pharmaphorum talked to the CEO of Infirst Healthcare Manfred Scheske about how he’s seen the consumer health sector deve...